A Case of Comorbid PTSD and Posttraumatic OCD Treated with Sertraline-Aripiprazole Augmentation.
Journal
Case reports in psychiatry
ISSN: 2090-682X
Titre abrégé: Case Rep Psychiatry
Pays: United States
ID NLM: 101583308
Informations de publication
Date de publication:
2020
2020
Historique:
received:
06
09
2019
revised:
10
01
2020
accepted:
16
01
2020
entrez:
13
2
2020
pubmed:
13
2
2020
medline:
13
2
2020
Statut:
epublish
Résumé
Several studies report on traumatic history in Obsessive Compulsive Disorder (OCD) and comorbidity between Posttraumatic Stress Disorder (PTSD) and OCD. First-line pharmacological treatments for both OCD and PTSD are primarily based on antidepressants, including Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Noradrenaline Reuptake Inhibitors (SNRI) such as Venlafaxine for PTSD. Second-Generation Antipsychotic (SGA) augmentation has shown good outcomes for nonresponsive OCD cases. However, evidence on the use of SGA in PTSD is more limited. In the present paper, we report on comorbid OCD-PTSD successfully treated with aripiprazole augmentation of sertraline. Shared psychopathological and pharmacological aspects of the disorders are discussed.
Identifiants
pubmed: 32047692
doi: 10.1155/2020/2616492
pmc: PMC7007739
doi:
Types de publication
Case Reports
Langues
eng
Pagination
2616492Informations de copyright
Copyright © 2020 Rodolfo Rossi et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Psychol Trauma. 2018 Jan;10(1):58-66
pubmed: 27929310
Br J Psychiatry. 2015 Feb;206(2):93-100
pubmed: 25644881
World Psychiatry. 2017 Feb;16(1):5-13
pubmed: 28127906
Arch Gen Psychiatry. 2005 Jun;62(6):617-27
pubmed: 15939839
Psychiatry Res. 2016 Oct 30;244:165-70
pubmed: 27479108
Front Behav Neurosci. 2017 Dec 11;11:240
pubmed: 29321734
J Anxiety Disord. 2012 Mar;26(2):377-83
pubmed: 22230220
Psychiatry Res. 2015 Oct 30;229(3):814-8
pubmed: 26277035
Soc Psychiatry Psychiatr Epidemiol. 2014 Aug;49(8):1287-96
pubmed: 24213522
JAMA. 2017 Apr 4;317(13):1358-1367
pubmed: 28384832
J Anxiety Disord. 2005;19(1):127-36
pubmed: 15488372
Fundam Clin Pharmacol. 1996;10(1):16-27
pubmed: 8900496
Health Psychol Behav Med. 2014 Jan 1;2(1):517-528
pubmed: 25750799
Drugs R D. 2018 Sep;18(3):167-189
pubmed: 30171515
Expert Opin Pharmacother. 2019 Jan;20(1):47-53
pubmed: 30360669
Psychopathology. 1999 Nov-Dec;32(6):319-24
pubmed: 10575330
J Clin Psychiatry. 2005 Jan;66(1):49-51
pubmed: 15669888
World J Biol Psychiatry. 2017 Apr;18(3):162-214
pubmed: 27419272
Expert Opin Drug Saf. 2019 Jun;18(6):455-463
pubmed: 31072228
Clin Neuropharmacol. 2017 Nov/Dec;40(6):273-278
pubmed: 29059134
J Behav Ther Exp Psychiatry. 2007 Dec;38(4):411-22
pubmed: 18005933
Psychiatr Danub. 2019 Jun;31(2):141-147
pubmed: 31291217
Psychiatry Res. 2019 Oct;280:112508
pubmed: 31401290
BMC Psychiatry. 2014;14 Suppl 1:S1
pubmed: 25081580
World J Biol Psychiatry. 2008;9(4):248-312
pubmed: 18949648